Kevin Madagan
USA Guide 2023
Band 3 : Healthcare: Pharmaceutical/Medical Products Regulatory
Band 3
About
Provided by Kevin Madagan
Practice Areas
Kevin is a health care and FDA regulatory attorney and partner in Reed Smith’s Life Sciences Health Industry Group. He advises on health care and FDA issues related to the manufacturing, distribution, and sale of drugs (Rx, OTC, homeopathic), biologics, devices (Rx and OTC), combination products, and dietary supplements.
Kevin’s clients include suppliers; manufacturers; repackagers; wholesale and private label distributors; clinical laboratories; third-party logistics providers; carriers; pharmacies (503A, 503B, nuclear and radiopharmacy operations); and health care providers.
Kevin advises strategic owners, private equity funds, underwriters and other public and privately-held businesses seeking particular FDA and health care support in connection with health care financing and securities transactions, and domestic and international mergers and acquisitions.
Kevin focuses on providing legal and strategic advice regarding supply chain logistics; commercialization activities; and health care compliance and enforcement. He is a member of the Editorial Advisory Board of Thompsons’ FDA Advertising and Promotion Manual and has served on numerous committees for the Food and Drug Law Institute, including the Medical Device Committee. He is also a long-standing planning committee member of the Drug Information Association’s annual Advertising and Promotion Regulatory Affairs Conference.
Kevin is a founding member of the Young Lawyers Committee for the Lawyer’s Committee on Civil Rights.